INMB – inmune bio inc. - common stock (US:NASDAQ)
Stock Stats
News
5/7
08:00 am
inmb
Low
INmune Bio Inc. to Report First Quarter 2024 Financial Results and Provide a Corporate Update on Thursday, May 9
4/30
08:17 am
inmb
Low
INmune Bio Inc. Provides Update on Two Patients from the Phase 1b Alzheimer's Disease Trial who Continue to Receive XPro™ Under Compassionate Use for Over Three Years [Yahoo! Finance]
4/30
08:00 am
inmb
Medium
INmune Bio Inc. Provides Update on Two Patients from the Phase 1b Alzheimer’s Disease Trial who Continue to Receive XPro™ Under Compassionate Use for Over Three Years
4/29
08:10 am
inmb
Low
INmune Bio Inc. Completes First Cohort and Initiates Second Cohort of Phase 1/2 Study of INKmune™ Natural Killer Cell Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer [Yahoo! Finance]
4/29
08:00 am
inmb
Medium
INmune Bio Inc. Completes First Cohort and Initiates Second Cohort of Phase 1/2 Study of INKmune™ Natural Killer Cell Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer
5/1
04:06 pm
inmb
Low
Form S-3 Inmune Bio, Inc.
4/30
04:02 pm
inmb
Low
Form 8-K Inmune Bio, Inc. For: Apr 29
4/26
04:29 pm
inmb
Medium
Form 8-K Inmune Bio, Inc. For: Apr 24
4/26
04:27 pm
inmb
Medium
Form 424B5 Inmune Bio, Inc.
4/25
04:35 pm
inmb
Low
Form 8-K Inmune Bio, Inc. For: Apr 23
Show more
Top News Gainers
3/11 Form 10-K Inmune Bio, Inc. For: Dec 31 26.3%
4/24 Form 424B3 Inmune Bio, Inc. 20.9%
10/21 Form 8-K Inmune Bio, Inc. For: Oct 16 13.8%
10/17 INmune Bio, Inc. Announces Presentation of Data Related to its Lead Compound XPro1595 at the Society for Neuroscience’s Annual Meeting 12.2%
12/17 INmune Bio Announces Final Phase I Clinical Data for its Soluble TNF Inhibitor, INB03, Demonstrates Efficacy and Safety; INB03 is Advancing to Phase II Trials 11.8%
9/4 INmune Bio Inc. to Introduce NeuLiv™ Program for Treatment of NASH at H.C. Wainwright 21st Annual Global Investment Conference 10.9%
8/21 Form 4 Inmune Bio, Inc. For: Aug 20 Filed by: Tesi Raymond Joseph 9.1%
4/20 INmune Bio, Inc. Announces Initiation of Clinical Program Targeting Soluble TNF to Determine if the Company’s TNF Inhibitor (DN-TNF) Platform May Prevent Complications of Cytokine Storm Caused by COVID-19 7.7%
9/4 Form 8-K Inmune Bio, Inc. For: Sep 04 7.7%
8/16 Form 3 Inmune Bio, Inc. For: Aug 06 Filed by: Baracchini Edgardo Jr 7.5%
Top News Decliners
3/11 INmune Bio Inc. (INMB) CEO R.J. Tesi on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] -29.8%
10/8 Form 8-K Inmune Bio, Inc. For: Oct 08 -13.2%
5/17 INmune Bio Inc (NASDAQ: INMB) was given a new $13.00 price target on by analysts at Maxim Group. They now have a "buy" rating on the stock. -12.3%
8/7 Form 8-K Inmune Bio, Inc. For: Aug 05 -12.2%
8/15 Form 8-K Inmune Bio, Inc. For: Aug 14 -9.8%
4/21 Form EFFECT Inmune Bio, Inc. -9.7%
4/3 Form EFFECT Inmune Bio, Inc. -8.3%
8/21 INmune Bio Inc (NASDAQ: INMB) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock. -8.2%
3/12 Form 8-K Inmune Bio, Inc. For: Mar 11 -8.0%
8/9 Form 8-K Inmune Bio, Inc. For: Aug 05 -7.8%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3